All Press Releases
LabCentral Alumni Sentien Biotechnologies Announces Open IND in Phase 1/2 Trial of SBI-101 for Patients with COVID-19
August 18, 2020
Astellas Commits Nearly $13 Million to Fund Boston-area Start-Up Innovation in Cell and Gene Therapy
October 1, 2019
Pfizer Inc. Awards “Golden Tickets” to Neutrolis and Mediar Therapeutics
September 27, 2019
SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors
September 6, 2019